Biolinq Inc.
05/09/2024 | Press release | Archived content
Biolinq Raises $58m
SAN DIEGO- Wearable tech startup Biolinq landed $58 million in funding to fuel the development of its ultra-tiny skin patch that uses electrochemical sensors to measure glucose levels in patients with metabolic syndromes like diabetes. The company's burgeoning success has the potential to shake up a glucose monitoring market that's dominated by heave hitters like Dexcom and Abbott. Read more at: https://www.sdbj.com/life-sciences/medical-devices/biolinq-raises-58m/
Biolinq Inc. published this content on May 09, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 26, 2026 at 10:23 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]